Headline
The latest stories from AHA Today.
To advance its efforts and achieve stated broader goals of ending structural racism in biomedical research, NIH has issued a Request for Information focused on best practices to identify opportunities, make recommendations, and develop and implement strategies to eliminate or lessen health…
The Centers for Medicare & Medicaid Services revised the application process for the Medicare Shared Saving Program to give accountable care organizations more time to apply to participate beginning Jan. 1, 2022.
The Food and Drug Administration issued an emergency use authorization for a next generation sequencing test to aid in identifying individuals with an adaptive T cell immune response indicating recent or prior infection with SARS-CoV-2.
Cities, counties and other local governments may apply through April 20 for grants to work with community-based organizations to encourage COVID-19 safety and vaccination in vulnerable and underserved populations.
The Senate Health, Education, Labor & Pensions Committee held a hearing to examine the COVID-19 response and receive an update from the front lines of the pandemic.
In honor of International Women's Day, Priya Bathija, AHA’s vice president of strategic initiatives, embraces this year’s theme, Choose to Challenge, and urges health care leaders to take action to improve the health of all women before, during and after pregnancy.
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response urged the health care and public health sector to patch on-premises Microsoft Exchange Server vulnerabilities announced last week, noting that additional criminal and state actors have been…
Regulators should prohibit health insurers from preventing hospitals and physicians in their networks from directly acquiring and storing drugs used in patient care, according to a white paper released today by AHA.
The National Academy of Medicine has named an international committee to assess how COVID-19 vaccine development and other policies could facilitate global efforts to prepare for seasonal flu and a flu pandemic.
The Food and Drug Administration authorized the first molecular test to detect the SARS-CoV-2 virus in a nasal swab at home without a prescription. Cue Health expects by summer to daily produce more than 100,000 of the tests, authorized for use in patients age 2 and older.